The inhibitory effect of IFN-γ on protease HTRA1 expression in rheumatoid arthritis

Journal of Immunology

Volumn 193, Issue 1, 2014, Pages 130-138

  Hou, Yuzhu ^a,b   Lin, Haijiang ^c   Zhu, Linnan ^a,b   Liu, Zhaoting ^a   Hu, Fanlei ^d   Shi, Jianfeng ^a,b   Yang, Tao ^a,b   Shi, Xiaoyun ^a,e   Guo, Huifang ^f   Tan, Xiaotian ^a   Zhang, Lianfeng ^g   Wang, Qiang ^a   Li, Zhanguo ^d   Zhao, Yong ^a,b  

^a INSTITUTE OF ZOOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c HARVARD MEDICAL SCHOOL   (United States)

^d PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^e GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^f HEBEI MEDICAL UNIVERSITY   (China)

^g BEIJING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN HTRA1; PROTEIN KINASE B; SERINE PROTEINASE; STAT1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; FIBROBLAST; HTRA1 GENE; HUMAN; HUMAN CELL; INCIDENCE; INTRACELLULAR SIGNALING; MACROPHAGE; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEFICIENCY; PROTEIN DEPLETION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN INDUCTION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; RNA INTERFERENCE; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION;

ANIMALS; ARTHRITIS, RHEUMATOID; CELL LINE; COLLAGEN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERFERON-GAMMA; JOINTS; LIPOPOLYSACCHARIDES; MICE; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROMOTER REGIONS, GENETIC; SERINE ENDOPEPTIDASES; STAT1 TRANSCRIPTION FACTOR;

EID: 84903625194     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302700     Document Type: Article

References (44)

1. Brennan, F. M., and I. B. McInnes. 2008. Evidence that cytokines play a role in rheumatoid arthritis. J. Clin. Invest. 118: 3537-3545.
2. Feldmann, M., and S. R. Maini. 2008. Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics. Immunol. Rev. 223: 7-19. (Pubitemid 351986171)
3. Le Goff, B., F. Blanchard, J. M. Berthelot, D. Heymann, and Y. Maugars. 2010. Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine 77: 201-205.
4. Irmler, I. M., M. Gajda, and R. Bräuer. 2007. Exacerbation of antigen-induced arthritis in IFN-γ-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 179: 6228-6236.
5. Manoury-Schwartz, B., G. Chiocchia, N. Bessis, O. Abehsira-Amar, F. Batteux, S. Muller, S. Huang, M. C. Boissier, and C. Fournier. 1997. High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J. Immunol. 158: 5501-5506. (Pubitemid 127681259)
6. Vermeire, K., H. Heremans, M. Vandeputte, S. Huang, A. Billiau, and P. Matthys. 1997. Accelerated collagen-induced arthritis in IFN-γ receptordeficient mice. J. Immunol. 158: 5507-5513. (Pubitemid 127681260)
7. Finckh, A., J. F. Simard, C. Gabay, and P. A. Guerne; SCQM physicians. 2006. Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis. Ann. Rheum. Dis. 65: 746-752.
8. Clausen, T., C. Southan, and M. Ehrmann. 2002. The HtrA family of proteases: implications for protein composition and cell fate. Mol. Cell 10: 443-455. (Pubitemid 35284166)
9. Tsuchiya, A., M. Yano, J. Tocharus, H. Kojima, M. Fukumoto, M. Kawaichi, and C. Oka. 2005. Expression of mouse HtrA1 serine protease in normal bone and cartilage and its upregulation in joint cartilage damaged by experimental arthritis. Bone 37: 323-336. (Pubitemid 41160491)
10. Polur, I., P. L. Lee, J. M. Servais, L. Xu, and Y. Li. 2010. Role of HTRA1, a serine protease, in the progression of articular cartilage degeneration. Histol. Histopathol. 25: 599-608.
11. Vierkotten, S., P. S. Muether, and S. Fauser. 2011. Overexpression of HTRA1 leads to ultrastructural changes in the elastic layer of Bruch's membrane via cleavage of extracellular matrix components. PLoS ONE 6: e22959.
12. Hoy, B., M. Löwer, C. Weydig, G. Carra, N. Tegtmeyer, T. Geppert, P. Schröder, N. Sewald, S. Backert, G. Schneider, and S. Wessler. 2010. Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E-cadherin to disrupt intercellular adhesion. EMBO Rep. 11: 798-804.
13. An, E., S. Sen, S. K. Park, H. Gordish-Dressman, and Y. Hathout. 2010. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. Invest. Ophthalmol. Vis. Sci. 51: 3379-3386.
14. Zumbrunn, J., and B. Trueb. 1996. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett. 398: 187-192. (Pubitemid 26414307)
15. Zhang, L., S. L. Lim, H. Du, M. Zhang, I. Kozak, G. Hannum, X. Wang, H. Ouyang, G. Hughes, L. Zhao, et al. 2012. High temperature requirement factor A1 (HTRA1) gene regulates angiogenesis through transforming growth factor-b family member growth differentiation factor 6. J. Biol. Chem. 287: 1520-1526.
16. Hu, S. I., M. Carozza, M. Klein, P. Nantermet, D. Luk, and R. M. Crowl. 1998. Human HtrA, an evolutionarily conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J. Biol. Chem. 273: 34406-34412. (Pubitemid 29008919)
17. Grau, S., P. J. Richards, B. Kerr, C. Hughes, B. Caterson, A. S. Williams, U. Junker, S. A. Jones, T. Clausen, and M. Ehrmann. 2006. The role of human HtrA1 in arthritic disease. J. Biol. Chem. 281: 6124-6129. (Pubitemid 43847541)
18. Wu, J., W. Liu, A. Bemis, E. Wang, Y. Qiu, E. A. Morris, C. R. Flannery, and Z. Yang. 2007. Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis. Arthritis Rheum. 56: 3675-3684. (Pubitemid 350100702)
19. Weger, M., W. Renner, I. Steinbrugger, K. Köfer, A. Wedrich, A. Groselj-Strele, Y. El-Shabrawi, O. Schmut, and A. Haas. 2007. Association of the HTRA1 -625G.A promoter gene polymorphism with exudative age-related macular degeneration in a Central European population. Mol. Vis. 13: 1274-1279. (Pubitemid 47128954)
20. Mullany, S. A., M. Moslemi-Kebria, R. Rattan, A. Khurana, A. Clayton, T. Ota, A. Mariani, K. C. Podratz, J. Chien, and V. Shridhar. 2011. Expression and functional significance of HtrA1 loss in endometrial cancer. Clin. Cancer Res. 17: 427-436.
21. Jones, A., S. Kumar, N. Zhang, Z. Tong, J. H. Yang, C. Watt, J. Anderson, H. Amrita, H. Fillerup, M. McCloskey, et al. 2011. Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice. Proc. Natl. Acad. Sci. USA 108: 14578-14583.
22. Bakay, M., P. Zhao, J. Chen, and E. P. Hoffman. 2002. A web-accessible complete transcriptome of normal human and DMD muscle. Neuromuscul. Disord. 12(Suppl. 1): S125-S141.
23. Murwantoko, M., M. Yano, Y. Ueta, A. Murasaki, H. Kanda, C. Oka, and M. Kawaichi. 2004. Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. Biochem. J. 381: 895-904. (Pubitemid 39120501)
24. Chien, J., G. Aletti, A. Baldi, V. Catalano, P. Muretto, G. L. Keeney, K. R. Kalli, J. Staub, M. Ehrmann, W. A. Cliby, et al. 2006. Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity. J. Clin. Invest. 116: 1994-2004. (Pubitemid 44033323)
25. Hou, Y., H. Lin, L. Zhu, Z. Liu, F. Hu, J. Shi, T. Yang, X. Shi, M. Zhu, B. F. Godley, et al. 2013. Lipopolysaccharide increases the incidence of collagen-induced arthritis in mice through induction of protease HTRA-1 expression. Arthritis Rheum. 65: 2835-2846.
26. Ma, H., G. Liu, W. Ding, Y. Wu, L. Cai, and Y. Zhao. 2008. Diabetes-induced alteration of F4/80+ macrophages: a study in mice with streptozotocin-induced diabetes for a long term. J. Mol. Med. 86: 391-400.
27. Sun, C., L. Sun, H. Ma, J. Peng, Y. Zhen, K. Duan, G. Liu, W. Ding, and Y. Zhao. 2012. The phenotype and functional alterations of macrophages in mice with hyperglycemia for long term. J. Cell. Physiol. 227: 1670-1679.
28. Inglis, J. J., C. A. Notley, D. Essex, A. W. Wilson, M. Feldmann, P. Anand, and R. Williams. 2007. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum. 56: 4015-4023. (Pubitemid 350262329)
29. Williams, R. O. 2004. Collagen-induced arthritis as a model for rheumatoid arthritis. Methods Mol. Med. 98: 207-216.
30. Liu, G., X. Hu, B. Sun, T. Yang, J. Shi, L. Zhang, and Y. Zhao. 2013. Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPKSTAT1. Blood 121: 519-529.
31. Jia, Y., and K. Takimoto. 2003. GATA and FOG2 transcription factors differentially regulate the promoter for Kv4.2 K+ channel gene in cardiac myocytes and PC12 cells. Cardiovasc. Res. 60: 278-287. (Pubitemid 37412361)
32. Rada-Iglesias, A., R. Bajpai, T. Swigut, S. A. Brugmann, R. A. Flynn, and J. Wysocka. 2011. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470: 279-283.
33. Huang, Q. Q., and R. M. Pope. 2009. The role of Toll-like receptors in rheumatoid arthritis. Curr. Rheumatol. Rep. 11: 357-364.
34. Kovarik, P., D. Stoiber, M. Novy, and T. Decker. 1998. Stat1 combines signals derived from IFN-γ and LPS receptors during macrophage activation. EMBO J. 17: 3660-3668. (Pubitemid 28327384)
35. Ramana, C. V., M. P. Gil, R. D. Schreiber, and G. R. Stark. 2002. Stat1- dependent and -independent pathways in IFN-γ-dependent signaling. Trends Immunol. 23: 96-101.
36. Kawai, T., and S. Akira. 2007. TLR signaling. Semin. Immunol. 19: 24-32. (Pubitemid 46498752)
37. Jacob, C. O., J. Holoshitz, P. Van der Meide, S. Strober, and H. O. McDevitt. Heterogeneous effects of IFN-γ in adjuvant arthritis. J. Immunol. 142: 1500-1505.
38. Kageyama, Y., Y. Koide, A. Yoshida, M. Uchijima, T. Arai, S. Miyamoto, T. Ozeki, M. Hiyoshi, K. Kushida, and T. Inoue. 1998. Reduced susceptibility to collagen-induced arthritis in mice deficient in IFN-γ receptor. J. Immunol. 161: 1542-1548. (Pubitemid 28380588)
39. Machold, K. P., K. Neumann, and J. S. Smolen. 1992. Recombinant human interferon g in the treatment of rheumatoid arthritis: double blind placebo controlled study. Ann. Rheum. Dis. 51: 1039-1043.
40. Tamassia, N., F. Calzetti, T. Ear, A. Cloutier, S. Gasperini, F. Bazzoni, P. P. McDonald, and M. A. Cassatella. 2007. Molecular mechanisms underlying the synergistic induction of CXCL10 by LPS and IFN-γ in human neutrophils. Eur. J. Immunol. 37: 2627-2634. (Pubitemid 47423630)
41. Ruschen, S., G. Lemm, and H. Warnatz. 1989. Spontaneous and LPS-stimulated production of intracellular IL-1 beta by synovial macrophages in rheumatoid arthritis is inhibited by IFN-γ. Clin. Exp. Immunol. 76: 246-251. (Pubitemid 19150396)
42. Wilke, C. M., K. Bishop, D. Fox, and W. Zou. 2011. Deciphering the role of Th17 cells in human disease. Trends Immunol. 32: 603-611.
43. Liu, Z. G. 2005. Molecular mechanism of TNF signaling and beyond. Cell Res. 15: 24-27.
44. Kunisch, E., M. Gandesiri, R. Fuhrmann, A. Roth, R. Winter, and R. W. Kinne. 2007. Predominant activation of MAP kinases and pro-destructive/pro- inflammatory features by TNFα in early-passage synovial fibroblasts via TNF receptor-1: failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis. Ann. Rheum. Dis. 66: 1043-1051. (Pubitemid 47122317)